Cargando…

Cutaneous Crohn’s disease after proctocolectomy for medically refractory colonic Crohn’s disease: a case series and review of the literature

BACKGROUND: Cutaneous Crohn’s disease (CCD), also known as metastatic Crohn’s disease (CD), is one of the rarest and most challenging cutaneous manifestations of CD. It is characterized by non-caseating granulomatous inflammation of the skin at sites that are non-contiguous with the gastrointestinal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naffouj, Sandra, Marrero-Rivera, Gabriel E., Nordenstam, Johan, Amber, Kyle T., Trivedi, Itishree
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2023
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304526/ https://www.ncbi.nlm.nih.gov/pubmed/37396002 http://dx.doi.org/10.20524/aog.2023.0811

Ejemplares similares

Role of surgery in the management of Crohn’s disease: a case series
por: Chandramohan, Janaki Krithika, et al.
Publicado: (2022)

Refractory cutaneous Crohn's disease of the external genitalia in a female
por: Goyal, Pallavi, et al.
Publicado: (2020)

The MYTHS of De novo Crohn’s Disease After Restorative Proctocolectomy with Ileal Pouch-anal Anastomosis for Ulcerative Colitis
por: James, SD, et al.
Publicado: (2020)

Anti-TNF Exposure during Pregnancy in Crohn's Disease Patients
por: Silva, Elen Farinelli de Campos, et al.
Publicado: (2018)

Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn's Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment
por: Suzuki, Taketo, et al.
Publicado: (2019)

Concomitant intestinal malrotation and Crohn’s disease: a rare and surgically challenging anomaly
por: Silverman, Jacob, et al.
Publicado: (2022)

Managing refractory Crohn’s disease: challenges and solutions
por: Tanida, Satoshi, et al.
Publicado: (2015)

Fecal microbiota transplantation for refractory Crohn's disease
por: Bak, Seon Ho, et al.
Publicado: (2017)

Primary Cutaneous Nocardiosis in an Adolescent with Crohn Disease
por: Svoboda, Steven A., et al.
Publicado: (2020)

Cutaneous Crohn Disease without Intestinal Manifestations
por: Vahabi-Amlashi, Sadegh, et al.
Publicado: (2021)

Combining infliximab, anti-MAP and hyperbaric oxygen therapy for resistant fistulizing Crohn's disease
por: Agrawal, Gaurav, et al.
Publicado: (2015)

Hidradenitis Suppurativa as a Paradoxical Side Effect to the Use of Adalimumab in Patients with Crohn’s Disease?
por: Beraldo, Rodrigo Fedatto, et al.
Publicado: (2020)

Morbidly Obese Patients with Ileocolic Crohn’s Disease May Benefit from Robotic Surgery
por: Blumberg, David
Publicado: (2021)

Refractory Duodenal Crohn's Disease Successfully Treated with Infliximab
por: Kim, You Lim, et al.
Publicado: (2014)

Ustekinumab for Successful Treatment of Refractory Esophageal Crohn’s Disease
por: Barkin, Jodie A., et al.
Publicado: (2016)

The management of chronic Crohn's disease.
por: Kyle, J.
Publicado: (1971)

Simultaneous development of sarcoidosis and cutaneous vasculitis in a patient with refractory Crohn’s disease during infliximab therapy
por: Numakura, Tadahisa, et al.
Publicado: (2016)

A179 AUTOLOGOUS BONE MARROW TRANSPLANT FOR REFRACTORY CROHN’S DISEASE: A CASE SERIES
por: Buttar, J, et al.
Publicado: (2022)

Quality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn Disease
por: Gauss, Annika, et al.
Publicado: (2016)

Cost of Refractory Crohn’s Disease Before and After Ustekinumab Utilization
por: Rahme, Elham, et al.
Publicado: (2019)

Refractory aphthae in the epiglottis and supraglottic area due to Crohn's disease
por: Hori, Hiroshi, et al.
Publicado: (2020)

Refractory metastatic Crohn’s disease responsive to ustekinumab dose intensification
por: Xiao, Teresa L., et al.
Publicado: (2022)

CROHN'S DISEASE
Publicado: (1972)

Crohn disease
por: Geller, Stephen A, et al.
Publicado: (2015)

Crohn's Disease
Publicado: (1973)

Is It Crohn’s Disease?
por: Parigi, Tommaso Lorenzo, et al.
Publicado: (2020)

Metastatic Crohn's Disease: An Approach to an Uncommon but Important Cutaneous Disorder
por: Aberumand, Babak, et al.
Publicado: (2017)

Gummatous cutaneous tuberculosis associated with the use of infliximab for Crohn's disease()()
por: Garcia, Lucas Campos, et al.
Publicado: (2021)

Colonic tuberculosis mimicking Crohn's disease: case report
por: Chatzicostas, Constantinos, et al.
Publicado: (2002)

Balloon dilatation of ileo-colonic anastomosis in Crohn’s disease
por: Katsanos, Konstantinos H., et al.
Publicado: (2012)

Quality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn Disease: Erratum
Publicado: (2016)

Chronic granulomatous disease mimicking early-onset Crohn’s disease with cutaneous manifestations
por: Barbato, Maria, et al.
Publicado: (2014)

Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease
por: Haider, Syedreza A., et al.
Publicado: (2020)

Adjunctive Hyperbaric Oxygen Therapy in Refractory Crohn's Disease: An Observational Study
por: Feitosa, Marley R., et al.
Publicado: (2021)

Mucosal Interleukin‐10 depletion in steroid‐refractory Crohn's disease patients
por: Carrasco, Anna, et al.
Publicado: (2022)

Hematopoietic Stem Cell Transplantation in Refractory Crohn’s Disease: Should It Be Considered?
por: Reider, Simon, et al.
Publicado: (2022)

Subcutaneous Infliximab in Refractory Crohn’s Disease Patients: A Possible Biobetter?
por: Cerna, Karin, et al.
Publicado: (2023)

Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn’s Disease
por: Rice, Shantini A, et al.
Publicado: (2013)

Metronidazole for the treatment of cutaneous vulval Crohn disease: A systematic review
por: Simon, Nina, et al.
Publicado: (2023)

Influence of Smoking on Colonic Gene Expression Profile in Crohn's Disease
por: Nielsen, Ole Haagen, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_gsq565njrnmlna5vkvdcv6nsk7